Inhibition of the NMDA receptor/Nitric Oxide pathway in the dorsolateral periaqueductal gray causes anxiolytic-like effects in rats submitted to the Vogel conflict test

Behavioral and Brain Functions

Volumn 5, Issue , 2009, Pages

  Tonetto, Lucas L M ^a   Terzian, Ana L ^a   Del Bel, Elaine A ^a   Guimarães, Francisco S ^a   Resstel, Leonardo B M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79957961935     PISSN: None     EISSN: 17449081     Source Type: Journal    
DOI: 10.1186/1744-9081-5-40     Document Type: Article

References (44)

1. Bandler R, Keay KA, Floyd N, Price J. Central circuits mediating patterned autonomic activity during active vs. passive emotional coping. Brain Res Bull 2000, 53(1):95-104. 10.1016/S0361-9230(00)00313-0, 11033213.
2. Carrive P. The periaqueductal gray and defensive behavior: functional representation and neuronal organization. Behav Brain Res 1993, 58(1-2):27-47. 10.1016/0166-4328(93)90088-8, 8136048.
3. Graeff FG. Serotonin, the periaqueductal gray and panic. Neurosci Biobehav Rev 2004, 28(3):239-259. 10.1016/j.neubiorev.2003.12.004, 15225969.
4. Krieger JE, Graeff FG. Defensive behavior and hypertension induced by glutamate in the midbrain central gray of the rat. Braz J Med Biol Res 1985, 18(1):61-67.
5. Bittencourt AS, Carobrez AP, Zamprogno LP, Tufik S, Schenberg LC. Organization of single components of defensive behaviors within distinct columns of periaqueductal gray matter of the rat: role of N-methyl-D-aspartic acid glutamate receptors. Neuroscience 2004, 125(1):71-89. 10.1016/j.neuroscience.2004.01.026, 15051147.
6. Aguiar DC, Moreira FA, Guimaraes FS. Flight reactions induced by injection of glutamate N-methyl-d-aspartate receptor agonist into the rat dorsolateral periaqueductal gray are not dependent on endogenous nitric oxide. Pharmacol Biochem Behav 2006, 83(2):296-301. 10.1016/j.pbb.2006.02.010, 16546244.
7. Albin RL, Makowiec RL, Hollingsworth Z, Dure L, Penney JB, Young AB. Excitatory amino acid binding sites in the periaqueductal gray of the rat. Neurosci Lett 1990, 118(1):112-115. 10.1016/0304-3940(90)90261-7, 2175406.
8. Guimaraes FS, Carobrez AP, De Aguiar JC, Graeff FG. Anxiolytic effect in the elevated plus-maze of the NMDA receptor antagonist AP7 microinjected into the dorsal periaqueductal grey. Psychopharmacology (Berl) 1991, 103(1):91-94. 10.1007/BF02244080, 1672463.
9. Molchanov ML, Guimaraes FS. Anxiolytic-like effects of AP7 injected into the dorsolateral or ventrolateral columns of the periaqueductal gray of rats. Psychopharmacology (Berl) 2002, 160(1):30-38. 10.1007/s00213-001-0941-x, 11862371.
10. Matheus MG, Guimaraes FS. Antagonism of non-NMDA receptors in the dorsal periaqueductal grey induces anxiolytic effect in the elevated plus maze. Psychopharmacology (Berl) 1997, 132(1):14-18. 10.1007/s002130050314, 9272754.
11. Contestabile A. Roles of NMDA receptor activity and nitric oxide production in brain development. Brain Res Brain Res Rev 2000, 32(2-3):476-509. 10.1016/S0165-0173(00)00018-7, 10760552.
12. Garthwaite J. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci 1991, 14(2):60-67. 10.1016/0166-2236(91)90022-M, 1708538.
13. Guimaraes FS, Beijamini V, Moreira FA, Aguiar DC, de Lucca AC. Role of nitric oxide in brain regions related to defensive reactions. Neurosci Biobehav Rev 2005, 29(8):1313-1322. 10.1016/j.neubiorev.2005.03.026, 16095696.
14. Resstel LB, Correa FM, Guimaraes FS. The expression of contextual fear conditioning involves activation of an NMDA receptor-nitric oxide pathway in the medial prefrontal cortex. Cereb Cortex 2008, 18(9):2027-2035. 10.1093/cercor/bhm232, 2517108, 18158326.
15. Guimaraes FS, de Aguiar JC, Del Bel EA, Ballejo G. Anxiolytic effect of nitric oxide synthase inhibitors microinjected into the dorsal central grey. Neuroreport 1994, 5(15):1929-1932.
16. Menard J, Treit D. Effects of centrally administered anxiolytic compounds in animal models of anxiety. Neurosci Biobehav Rev 1999, 23(4):591-613. 10.1016/S0149-7634(98)00056-6, 10073896.
17. Carlson JN, Haskew R, Wacker J, Maisonneuve IM, Glick SD, Jerussi TP. Sedative and anxiolytic effects of zopiclone's enantiomers and metabolite. Eur J Pharmacol 2001, 415(2-3):181-189. 10.1016/S0014-2999(01)00851-2, 11274997.
18. Flores P, Pellon R. Antipunishment effects of diazepam on two levels of suppression of schedule-induced drinking in rats. Pharmacol Biochem Behav 2000, 67(2):207-214. 10.1016/S0091-3057(00)00313-0, 11124383.
19. Griebel G, Perrault G, Letang V, Granger P, Avenet P, Schoemaker H, Sanger DJ. New evidence that the pharmacological effects of benzodiazepine receptor ligands can be associated with activities at different BZ (omega) receptor subtypes. Psychopharmacology (Berl) 1999, 146(2):205-213. 10.1007/s002130051108, 10525757.
20. Griebel G, Perrault G, Tan S, Schoemaker H, Sanger DJ. Comparison of the pharmacological properties of classical and novel BZ-omega receptor ligands. Behav Pharmacol 1999, 10(5):483-495.
21. Vogel JR, Beer B, Clody DE. A simple and reliable conflict procedure for testing anti-anxiety agents. Psychopharmacologia 1971, 21(1):1-7. 10.1007/BF00403989, 5105868.
22. Millan MJ, Brocco M. The Vogel conflict test: procedural aspects, gamma-aminobutyric acid, glutamate and monoamines. Eur J Pharmacol 2003, 463(1-3):67-96. 10.1016/S0014-2999(03)01275-5, 12600703.
23. Paxinos G, Watson C. The rat brain in stereotaxic coordinates 1997, San Diego, CA.: Academic press inc, Fourth.
24. Lisboa SF, Resstel LB, Aguiar DC, Guimaraes FS. Activation of cannabinoid CB1 receptors in the dorsolateral periaqueductal gray induces anxiolytic effects in rats submitted to the Vogel conflict test. Eur J Pharmacol 2008, 593(1-3):73-78. 10.1016/j.ejphar.2008.07.032, 18691568.
25. Resstel LB, Souza RF, Guimaraes FS. Anxiolytic-like effects induced by medial prefrontal cortex inhibition in rats submitted to the Vogel conflict test. Physiol Behav 2008, 93(1-2):200-205. 10.1016/j.physbeh.2007.08.009, 17884112.
26. Pajolla GP, Pelosi GG, Correa FM. Involvement of NMDA receptors in the hypotensive response to the injection of L-glutamate into the lateral hypothalamus of unanesthetized rats. Brain Res 2005, 1053(1-2):19-26. 10.1016/j.brainres.2005.05.056, 16038883.
27. Resstel LB, Correa FM. Injection of l-glutamate into medial prefrontal cortex induces cardiovascular responses through NMDA receptor - nitric oxide in rat. Neuropharmacology 2006, 51(1):160-167. 10.1016/j.neuropharm.2006.03.010, 16678863.
28. Benveniste M, Mayer ML. Kinetic analysis of antagonist action at N-methyl-D-aspartic acid receptors. Two binding sites each for glutamate and glycine. Biophys J 1991, 59(3):560-573. 10.1016/S0006-3495(91)82272-X, 1281221, 1710938.
29. Dhruva A, Bhatnagar T, Sapru HN. Cardiovascular responses to microinjections of glutamate into the nucleus tractus solitarii of unanesthetized supracollicular decerebrate rats. Brain Res 1998, 801(1-2):88-100. 10.1016/S0006-8993(98)00550-2, 9729297.
30. Adamec RE, Burton P, Shallow T, Budgell J. NMDA receptors mediate lasting increases in anxiety-like behavior produced by the stress of predator exposure--implications for anxiety associated with posttraumatic stress disorder. Physiol Behav 1999, 65(4-5):723-737. 10.1016/S0031-9384(98)00226-1, 10073474.
31. Jessa M, Nazar M, Bidzinski A, Plaznik A. The effects of repeated administration of diazepam, MK-801 and CGP 37849 on rat behavior in two models of anxiety. Eur Neuropsychopharmacol 1996, 6(1):55-61. 10.1016/0924-977X(95)00068-Z, 8866939.
32. Singewald N, Salchner P, Sharp T. Induction of c-Fos expression in specific areas of the fear circuitry in rat forebrain by anxiogenic drugs. Biol Psychiatry 2003, 53(4):275-283. 10.1016/S0006-3223(02)01574-3, 12586446.
33. Singewald N. Altered brain activity processing in high-anxiety rodents revealed by challenge paradigms and functional mapping. Neurosci Biobehav Rev 2007, 31(1):18-40. 10.1016/j.neubiorev.2006.02.003, 16620984.
34. Russo AS, Guimaraes FS, De Aguiar JC, Graeff FG. Role of benzodiazepine receptors located in the dorsal periaqueductal grey of rats in anxiety. Psychopharmacology (Berl) 1993, 110(1-2):198-202. 10.1007/BF02246973, 7870885.
35. Terzian AL, Aguiar DC, Guimaraes FS, Moreira FA. Modulation of anxiety-like behaviour by Transient Receptor Potential Vanilloid Type 1 (TRPV1) channels located in the dorsolateral periaqueductal gray. Eur Neuropsychopharmacol 2008,
36. Garthwaite J, Boulton CL. Nitric oxide signaling in the central nervous system. Annu Rev Physiol 1995, 57:683-706. 10.1146/annurev.ph.57.030195.003343, 7539993.
37. Onstott D, Mayer B, Beitz AJ. Nitric oxide synthase immunoreactive neurons anatomically define a longitudinal dorsolateral column within the midbrain periaqueductal gray of the rat: analysis using laser confocal microscopy. Brain Res 1993, 610(2):317-324. 10.1016/0006-8993(93)91416-P, 7686435.
38. Hevel JM, White KA, Marletta MA. Purification of the inducible murine macrophage nitric oxide synthase. Identification as a flavoprotein. J Biol Chem 1991, 266(34):22789-22791.
39. Martasek P, Liu Q, Liu J, Roman LJ, Gross SS, Sessa WC, Masters BS. Characterization of bovine endothelial nitric oxide synthase expressed in E. coli. Biochem Biophys Res Commun 1996, 219(2):359-365. 10.1006/bbrc.1996.0238, 8604992.
40. Zhang HQ, Fast W, Marletta MA, Martasek P, Silverman RB. Potent and selective inhibition of neuronal nitric oxide synthase by N omega-propyl-L-arginine. J Med Chem 1997, 40(24):3869-3870. 10.1021/jm970550g, 9397167.
41. Ko GY, Kelly PT. Nitric oxide acts as a postsynaptic signaling molecule in calcium/calmodulin-induced synaptic potentiation in hippocampal CA1 pyramidal neurons. J Neurosci 1999, 19(16):6784-6794.
42. File SE. Behavioural detection of anxiolytic action. Experimental Approaches to Anxiety and Depression 1992, 25-44. DJHaCAM. New York, Elliott JM.
43. Volke V, Koks S, Vasar E, Bourin M, Bradwejn J, Mannisto PT. Inhibition of nitric oxide synthase causes anxiolytic-like behaviour in an elevated plus-maze. Neuroreport 1995, 6(10):1413-1416. 10.1097/00001756-199507100-00013, 7488737.
44. Volke V, Soosaar A, Koks S, Vasar E, Mannisto PT. L-Arginine abolishes the anxiolytic-like effect of diazepam in the elevated plus-maze test in rats. Eur J Pharmacol 1998, 351(3):287-290. 10.1016/S0014-2999(98)00364-1, 9721019.